Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry

BACKGROUND: The use of Renin-Angiotensin system inhibitors (RASi) in patients with coronavirus disease 2019 (COVID-19) has been questioned because both share a target receptor site. METHODS: HOPE-COVID-19 (NCT04334291) is an international investigator-initiated registry. Patients are eligible when d...

Full description

Saved in:
Bibliographic Details
Published in:Am Heart J
Main Authors: Núñez-Gil, Iván J., Olier, Iván, Feltes, Gisela, Viana-Llamas, María C., Maroun-Eid, Charbel, Romero, Rodolfo, Fernández-Rozas, Inmaculada, Uribarri, Aitor, Becerra-Muñoz, Victor M., Alfonso-Rodriguez, Emilio, García-Aguado, Marcos, Elola, Javier, Castro-Mejía, Alex, Pepe, Martino, Garcia-Prieto, Juan Fortunato, Gonzalez, Adelina, Ugo, Fabrizio, Cerrato, Enrico, Bondia, Elvira, Raposeiras-Roubin, Sergio, Mendez, Jorge L. Jativa, Espejo, Carolina, López-Masjuan, Álvaro, Marin, Francisco, López-Pais, Javier, Abumayyaleh, Mohammad, Corbi-Pascual, Miguel, Liebetrau, Christoph, Ramakrishna, Harish, Estrada, Vicente, Macaya, Carlos, Fernandez-Ortiz, Antonio
Format: Artigo
Language:Inglês
Published: Elsevier Inc. 2021
Subjects:
Clinical Investigations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047303/
https://ncbi.nlm.nih.gov/pubmed/33845032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2021.04.001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items